NEW YORK — Radio personality and book author Delilah told an audience at Vision Expo East that eye care providers can change lives with free eye exams.
NEW YORK — A Tarsus executive said the company is looking forward to FDA approval of TP-03, a 0.25% lotilaner ophthalmic solution for treatment of Demodex blepharitis, in late summer 2023.
NEW YORK — Lumenis, makers of the OptiLight intense pulsed light treatment for dry eye, released the next generation of the device to decrease treatment time and improve workflow, according to a company executive at Vision Expo East.
NEW YORK — Nearly a quarter of more than 2,000 contact lens and spectacle wearers surveyed said they wear both modalities to correct their vision, according to a report from the Contact Lens Institute presented at Vision Expo East.
NEW YORK — CooperVision introduced its “Make Children’s Sight Your Fight” advocacy and education campaign during a press conference at Vision Expo East.